A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
Clinical trial NCT02409342 · COMPLETED
Trial details
- NCT number
- NCT02409342
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-20
- Primary completion
- 2020-02-04
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.